Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - OTHER CURRENT LIABILITIES
Other Current Liabilities ALNY - Alnylam Pharmaceuticals, Inc.
1 B
LAST VALUE
35.43%
2 YEAR CAGR
38.38%
5 YEAR CAGR
33.57%
10 YEAR CAGR